KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to -$277000.0.

  • Neogenomics' Cash from Investing Activities rose 9212.17% to -$277000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.5 million, marking a year-over-year decrease of 13237.32%. This contributed to the annual value of $12.9 million for FY2024, which is 8324.14% down from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Cash from Investing Activities is -$277000.0, which was up 9212.17% from -$9.3 million recorded in Q2 2025.
  • Neogenomics' Cash from Investing Activities' 5-year high stood at $23.7 million during Q1 2023, with a 5-year trough of -$453.4 million in Q2 2021.
  • In the last 5 years, Neogenomics' Cash from Investing Activities had a median value of -$1.1 million in 2022 and averaged -$28.9 million.
  • Per our database at Business Quant, Neogenomics' Cash from Investing Activities plummeted by 239633.87% in 2021 and then surged by 171759.17% in 2023.
  • Over the past 5 years, Neogenomics' Cash from Investing Activities (Quarter) stood at -$9.6 million in 2021, then surged by 88.91% to -$1.1 million in 2022, then surged by 1717.59% to $17.2 million in 2023, then tumbled by 131.79% to -$5.5 million in 2024, then surged by 94.93% to -$277000.0 in 2025.
  • Its Cash from Investing Activities was -$277000.0 in Q3 2025, compared to -$9.3 million in Q2 2025 and $3.6 million in Q1 2025.